New Scientist Colab Podcasts

New Scientist Colab Podcasts

DMG Media
Country USA
Language EN
Episodes 16
Latest 15.07.2026

Podcasts for the insatiably curious, produced by New Scientist in collaboration with carefully selected external parties. Hosted on Acast. See acast.com/privacy for more information.

Episodes

  • Inside the science of making medicines pure
    Inside the science of making medicines pure 15.07.2026 44m
    Show Notes 💬 Artificial intelligence and big data are flooding discovery pipelines with high-potential drug candidates, but this rapid innovation has triggered significant challenges. Simply put, our capability to design miracle molecules is vastly outstripping our technology to mass-manufacture them safely for the global public. Moving drug making from the scale of lab flasks to commercial bioreactors introduces non-linear biological and engineering shifts that can undermine tasks like purification. ⚡In this New Scientist CoLab podcast, experts from global life sciences leader Cytiva explai...
  • Discover how the science of healthspan helps keep pets thriving for longer
    Discover how the science of healthspan helps keep pets thriving for longer 02.07.2026 40m
    💬 The longevity space isn’t just for humans. Science is uncovering new ways to keep our pets healthier for longer too. New research is finally uncovering why our dogs and cats slow down with age - and how we can slow that process. ⚡ So what lifestyle changes can help our pets live longer, healthier lives? In this episode, sponsored by Royal Canin, we explore emerging research exploring the hallmarks of ageing, with practical tips for all pet owners. Our guests are: Dr Tanya Schoeman, veterinary specialist physician with Royal Canin Dr Cat Henstridge, veterinary surgeon and online educator (@...
  • What lies beneath? The new era of Earth imaging
    What lies beneath? The new era of Earth imaging 18.06.2026 32m
    💬 Over the last decade, advances in subsurface imaging have meant we’re able to see deep within our planet with unfathomable detail - pinpointing vast geological structures beneath our oceans with unprecedented accuracy. ⚡ Viridien is the company creating these incredible images and in this episode they explore the breakthroughs that are revolutionising subsurface imaging and helping to see the geological details of the Earth in ever higher definition. Our guests are: Gordon Poole, UK research manager at Viridien Ewa Kaszycka UK, Geoscience Manager at Viridien. Don't miss an episode - subscr...
  • The future of Humanity, decoded in London
    The future of Humanity, decoded in London 09.04.2026 30m
    About this episode SXSW London is the preeminent forum for the new ideas and leading thinkers who are sculpting the future. In this episode, we talk to Kat Sherling, head of conference at the event to explore the cultural and technological forces driving the agenda at this year’s festival and discover some of the speakers who will be there in June. This is a New Scientist CoLab production, sponsored by the SXSW London. Your host is Justin Mullins. Find out more about how we’re adapting to a rewired world with this New Scientist CoLab article : https://www.newscientist.com/article/2517346-can-h...
  • How UK and Spanish scientists are reimagining the future of green pharma
    How UK and Spanish scientists are reimagining the future of green pharma 19.02.2026 27m
    The production of medicines is a high-stakes industry where efficiency and environmental impact often collide. Given that the pharmaceutical industry is one of society’s biggest polluters, solving this challenge requires massive, cross-continent collaboration to spark real change. In this episode, we explore how some of the UK and Europe’s premier research institutes and pharmaceutical companies have joined forces to pioneer "greener" production methods. This work is funded by Horizon Europe, the European Union’s flagship €96 billion research and innovation funding programme. We visit Barcelon...
  • Discover Vanguard, the future of ocean research
    Discover Vanguard, the future of ocean research 20.11.2025 30m
    Imagine humans one day living and working on the ocean floor. Aquanauts in subsea habitats, surrounded by ocean creatures, discovering new secrets about our planet. This might sound like science fiction, but DEEP is already making this a reality. With the recent launch of its subsea habitat Vanguard, DEEP is pushing forward with its promise to make humans aquatic. An engineering company pushing the boundaries of what’s possible, DEEP exists to radically advance how humankind can access, explore and inhabit underwater environments. In this episode, Sophie Bushwick speaks to DEEP’s Chief Technol...
  • Inside the UK’s Energy Revolution
    Inside the UK’s Energy Revolution 17.09.2025 33m
    The UK’s energy system is undergoing a quiet revolution. As we move away from fossil fuels towards a cleaner, more flexible, and electrified future, Octopus Energy is helping to turn the traditional power grid on its head. In this episode of New Scientist CoLab, Justin Mullins is joined by Kieron Stopforth, Head of Flexibility at Octopus Energy. Kieron explains how the way we generate, store and use electricity is changing - and why your home, solar panels, and even your car could be part of the solution. This is a New Scientist CoLab production, sponsored by Octopus Energy. Your host is Justi...
  • A world without dementia? The science and hope ahead
    A world without dementia? The science and hope ahead 11.09.2025 35m
    Dementia is the UK’s leading cause of death, and one in three people born today will develop it in their lifetime. With numbers steadily rising, the need for effective treatments and improved dementia diagnosis is more urgent than ever. Thankfully, recent advances in science mean we understand the diseases that cause dementia better than ever. There has never been a more exciting time in dementia research, and supporting some of the most pioneering work in this field is UK charity Alzheimer’s Society. In this episode of the New Scientist CoLab podcast, Justin Mullins is joined by Richard Oakle...
  • How Vertex Pharmaceuticals is revolutionising drug discovery
    How Vertex Pharmaceuticals is revolutionising drug discovery 07.09.2025 19m
    What does it take to tackle the world’s most complex diseases? For David Price, head of the Vertex Pharmaceuticals Oxford Research site, the motivation is deeply personal. In this podcast from New Scientist CoLab, David shares his incredible journey and gives a detailed look inside Vertex, the company that pioneered patient-first drug discovery. Learn about their unique serial innovation strategy, which focuses on treating the underlying cause of a disease, not just the symptoms. He also discusses how automation and robotics are transforming the lab and why talented students and interns repres...
  • Women in Science Episode 4: Inside the world of nuclear test monitoring
    Women in Science Episode 4: Inside the world of nuclear test monitoring 17.07.2025 34m
    Meet a woman who works at the frontlines of global nuclear monitoring. In this special series of New Scientist CoLab interviews, where we spotlight exceptional women driving progress in science, technology, engineering, and mathematics. Jenny is the leader of AWE’s forensic seismology team and Lead UN Inspector for the Comprehensive Nuclear Test Ban Treaty Organisation, which carries out large-scale inspections across the globe. She walks us through everything from what might prompt an inspection to what actually happens on the ground, highlighting just how complex these high-stakes missions a...
  • Women in Science Episode 3: From the classroom to global defence leader
    Women in Science Episode 3: From the classroom to global defence leader 17.07.2025 32m
    Hear an inspiring story of career transformation, leadership, and purpose-driven science. In this special series of New Scientist CoLab interviews, we spotlight exceptional women driving progress in science, technology, engineering, and mathematics. Lorna is a Senior Science Manager at AWE, a technology and security organisation supporting the UK's nuclear deterrent. She’s the Acting Group Leader of Defence Radiation Protection Services at AWE, leading a team of 71 specialists. Lorna’s story is a reminder that STEM careers can begin in the most unexpected places as she shares her unconventiona...
  • Women In Science Episode 1 : The engineer behind the UK’s nuclear deterrent
    Women In Science Episode 1 : The engineer behind the UK’s nuclear deterrent 19.06.2025 26m
    A rare behind-the-scenes look at what it means to lead critical engineering work in one of the most secure and technologically advanced environments in the country. In this special series of New Scientist CoLab interviews, we spotlight exceptional women driving progress in science, technology, engineering, and mathematics. This episode is a deep dive into the world of high-stakes engineering, leadership, and innovation at the cutting edge of national security. Helen is Group Leader for Engineering at AWE, a technology and security organisation supporting the UK's nuclear deterrent. She’s a Mem...
  • Women in Science Episode 2: Challenges of developing a nuclear warhead
    Women in Science Episode 2: Challenges of developing a nuclear warhead 19.06.2025 34m
    Uncover 20 years of experience working in hydrodynamics, radiography and groundbreaking nuclear threat reduction projects. In this special series of New Scientist CoLab interviews, we spotlight exceptional women driving progress in science, technology, engineering, and mathematics. Stacey is Production Engineer at AWE, the technology and security organisation behind the UK’s nuclear deterrent. Today, she leads a team developing components for Astraea - the UK’s next-generation nuclear warhead programme. We explore: ● Stacey’s remarkable two-decade journey through science and engineering ● The...
  • Integrating Scientific Innovation and Health Equity
    Integrating Scientific Innovation and Health Equity 17.07.2024 17m
    For more than 35 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research. These advances have transformed the outlook for people affected by HIV worldwide. In parallel, Gilead’s focus on catalytic collaborations at the global, national and local levels have helped to address the unmet needs of a wide range of individuals and communities. Jared Baeten is a physician, epidemiologist and head of R&D at Gilead Sciences who has spent decades working in partnership with collaborators around the world to help overcome the HIV epidemi...
  • Industrial AI and the sustainability revolution - with Pina Schlombs from Siemens
    Industrial AI and the sustainability revolution - with Pina Schlombs from Siemens 29.05.2024 29m
    Artificial Intelligence is revolutionising manufacturing and transforming the industrial world. From solving challenges thought unsolvable, to improving efficiency and sustainability, AI is a new type of industrial revolution that reduces energy usage and waste. And at its helm is global technology company Siemens. Pina Schlombs is an expert on sustainability and AI at Siemens and in this episode she discusses: A robot gripper showcasing the power of industrial AI to solve complex engineering problems in a way that reduces their environmental impact. How industrial copilots are transforming th...
  • Transforming clinical trials: Episode 3
    Transforming clinical trials: Episode 3 28.02.2024 20m
    As the UK transforms its ecosystem for clinical trials, the regulatory landscape is undergoing its biggest change in 20 years. In this third episode of this free New Scientist podcast, we meet Dr Melanie Ivarsson, from the global biotechnology company Moderna, to find out why she chose the UK for a billion-pound research and development program. Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency Hosted on Acast. See acast.com/privacy for more information. Learn more about your ad choices. Visit megaphone.fm/adchoices
  • Transforming clinical trials: Episode 2
    Transforming clinical trials: Episode 2 21.02.2024 18m
    As the UK transforms its ecosystem for clinical trials, the regulatory landscape is undergoing its biggest change in 20 years. In this free New Scientist podcast, we meet Professor Andrea Manfrin whose team is responsible for driving this change at the Medicines and Healthcare products Regulatory Agency. Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency Hosted on Acast. See acast.com/privacy for more information. Learn more about your ad choices. Visit megaphone.fm/adchoices
  • Transforming clinical trials: Episode 1
    Transforming clinical trials: Episode 1 14.02.2024 30m
    The UK has long been a world leader for clinical trials and life sciences research. But after losing ground post-COVID and post-Brexit, the country has begun to rethink the landscape for clinical trials. In this free New Scientist podcast, we meet the chair of the UK review into commercial clinical trials, James O'Shaughnessy, and ask how the independent review has influenced the reinvention of the clinical trials infrastructure for a new age of medicine. Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency Hosted on Acast. See acast...

Popular in

The podcast also appears in the podcast charts of these countries.